Characterization of breakthrough pain by hospice patients and their caregivers

Journal of Pain and Symptom Management

Volumn 16, Issue 3, 1998, Pages 179-183

  Fine, Perry G ^a,c   Busch, Michael A ^b  

^a VistaCare   (United States)

^b Anesta Corporation   (United States)

^c PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

Author keywords

Analgesia; Breakthrough pain; Hospice; Incident pain

Indexed keywords

OPIATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PAIN; CAREGIVER; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HOSPICE; HUMAN; MALE; PAIN ASSESSMENT; SCHOOL CHILD; SELF REPORT;

ADOLESCENT; ADULT; AGED; CAREGIVERS; CHILD; FEMALE; HOSPICE CARE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; QUESTIONNAIRES;

EID: 0032168477     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(98)00045-1     Document Type: Article

References (13)

1. 1. Bonica JJ. Cancer pain. In: Bonica JJ, ed. The management of pain. Philadelphia; Lea and Febiger, 1990:400-434.
2. 2. Portenoy RK, Hagen NA. Breakthrough pain: definition and management. Oncology 1989; 3(suppl):25-29.
3. 3. Patt RB. Classification of cancer pain and cancer pain syndromes. In: Patt RB, ed. Cancer pain. Philadelphia: JB Lippincott Co., 1993:3-22.
4. 4. Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain 1990; 41:273-281.
5. 5. Bruera E, Macmillan K, Kuehn N, Miller MJ. Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain. A preliminary report. Pain 1992;49:311-314.
6. 6. Lynn J, Teno J, Phillips R, et al. Perceptions by family members of dying experience of older and seriously ill patients. Ann Intern Med 1997;126:97-106.
7. 7. Fine PG. Advances in cancer pain management. In: Lake CL, Rice LJ, Sperry RJ, eds. Advances in anesthesia. St. Louis: Mosby, 1995:133-158.
8. 8. Ashburn MA, Fine PG, Stanley TH. Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain. Anesthesiology 1989;71615-617.
9. 9. Fine PG, Marcus M, DeBoer AJ, Van der Oord B. An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain. Pain 1991;45:149-153.
10. 10. Simmonds MA. Oral transmucosal fentanyl citrate produces pain relief faster than medication typically used for breakthrough pain in cancer patients. American Society of Clinical Oncology (ASCO) Annual Meeting, 1997.
11. 11. Lyss AP. Long-term use of oral transmucosal fentanyl citrate (OTFC) for breakthrough pain in cancer patients. American Society of Clinical Oncology (ASCO) Annual Meeting, 1997.
12. 12. Coluzzi P. A titration study of oral transmucosal fentanyl citrate for breakthrough pain in cancer patients. American Society of Clinical Oncology (ASCO) Annual Meeting, 1997.
13. 13. Cleary JF. Double-blind randomized study of the treatment of breakthrough pain in cancer patients: Oral transmucosal fentanyl citrate vs placebo. American Society of Clinical Oncology (ASCO) Annual Meeting, 1997.